CCCC vs GME · rev $12.8M vs P/E 16, rev $3.63B
C4 Therapeutics Inc (CCCC) versus GameStop Corp. (GME) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
GameStop Corp. (GME) is a specialty retail company listed on US.
Latest reported CCCC revenue for 2026-06-30 was $12.8M. Net income was -$48.8M. CCCC currently screens at market cap $425.7M.
Latest reported GME revenue for 2026-01-31 was $3.63B. Net income was $418.4M. Revenue was down 5.1% from 2025-02-01 to 2026-01-31. GME currently screens at market cap $9.78B and trailing P/E 16.3.
CCCC currently screens at market cap $425.7M. GME currently screens at market cap $9.78B and trailing P/E 16.3.
Not investment advice. Open the CCCC and GME stock pages for the full models.
Not investment advice.